The effect of neurofeedback with pharmacotherapy in treatment of patients with obsessive – compulsive disorder
Phase 2
- Conditions
- obsessive – compulsive disorder.Obsessive-compulsive disorder
- Registration Number
- IRCT2015030321313N1
- Lead Sponsor
- Vice chancellor for research and Technology, Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Diagnosis of obsessive-compulsive disorder based on the psychiatrist's interview According to DSM-5 criteria, Taking sertraline, Be at least 18 and up to 60 years, The ability to read and write, A minimum score of 16 on the Yale Brown Obsessive Compulsive Scale. Exclusion criteria: The people with acute and serious mental disorders such as bipolar disorder, schizophrenia, etc, People with other medical illnesses such as head injuries, Neurologic Diseases, drug allergies, A history of substance abuse, The types of dementia and cognitive disabilities.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of symptoms of OCD. Timepoint: before and after the intervention. Method of measurement: Y_BOCS and CGI Scale.
- Secondary Outcome Measures
Name Time Method Cognitive ability and executive function. Timepoint: before and after the intervention. Method of measurement: Wisconsin, Stroop and Pasat tests.